Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Clorazepate dipotassium
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Dipotassium clorazepate 15mg capsules
0401020V0AAABAB
|
Clorazepate dipot | Clorazepate dipotassium | Central Nervous System | No data available |
|
Dipotassium clorazepate 7.5mg capsules
0401020V0AAAAAA
|
Clorazepate dipot | Clorazepate dipotassium | Central Nervous System | No data available |
|
Tranxene 15mg capsules
0401020V0BBABAB
|
Tranxene | Clorazepate dipotassium | Central Nervous System | No data available |
|
Tranxene 7.5mg capsules
0401020V0BBAAAA
|
Tranxene | Clorazepate dipotassium | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.